Take a look at performance of these ASX-listed stocks

Highlights,Chimeric welcomes Dr Stephanie H. Astrow as Vice President of Translational Sciences.,Dr Astrow has over two decades of experience in the fields of biotechnology and cell therapy.,She has extensive expertise in autologous as well as allogenic s...

Interested in cryptocurrency trading? We totally get it! The influence of online assets, which market participants can buy, store, or trade, has skyrocketed. With the emergence of novel business models and tech innovations, many individuals and industries...

The S&P/ASX 200 Materials sector has closed in green today. Let us see how the mining companies have fared today.

EarlyBirds platform can help various stakeholders in the hydrogen space to develop, find and implement suitable innovations.

Highlights,IOUpay is strategically collaborating with IDSB to provide instalment-based consumer finance to Malaysia’s Federal Civil Servants.,The first project includes short-term bridging loans provided by IOUpay, which feed into 10-year term loans facil...

The ASX 200 benchmark index closed up today, gaining 1.77% to 6,848.70 point.

Highlights,Invion has secured positive screening results from the in vitro study of Photosoft,TM,technology against the Zika virus.,Currently, there is no treatment available for the Zika virus, and its market is estimated to be worth $25bn and will grow ...

Highlights,Imugene has completed dosing the first patient in the nextHERIZON Phase 2 clinical trial in HER-Vaxx, IMU’s cancer immunotherapy,The clinical trial is focused on studying HER-Vaxx in combination with chemotherapy or pembrolizumab in patients di...

Highlights,Alchemy Resources has signed two Heritage Protection Agreements for its Karonie and Lake Rebecca projects.,The agreements will cover 17 exploration licences across the two Western Australian projects.,The agreements will enable Alchemy to build...

Highlights,Prescient has entered into a strategic collaboration with MD Anderson, the biggest cancer centre in the US.,The collaboration, aimed at developing flexible CAR-T cell therapies, will combine Prescient's OmniCAR platform with an undisclosed, pro...